Search

everythinglearnresearchcommunity

for

Search:↓

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Both books are valuable resources in their fields.

Hormone therapy can improve mental health and quality of life for people with gender dysphoria, but long-term effects need more research.

The book provides a historical view of abortion in the U.S., critiques the pro-choice movement, and recommends including abortion in medical education.

The book details advanced techniques in cosmetic dermatology for experienced surgeons.

Feeling shame can make it harder for people with diabetes to take care of their health.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Spironolactone might cause painful intercourse and decreased sexual arousal in women.

Hair loss in women linked to higher sexual dysfunction risk.

Local testosterone treatment improved sexual desire in a female with fragile X syndrome.

Stem cell treatment improved life quality and sexual function in women with hair loss.

Many different biological, psychological, and social factors can cause sexual dysfunction in American women.

Too much male hormone in mothers can negatively affect the sexual behavior of both male and female baby mice.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Women with PCOS often have sexual problems, and treating these issues early can improve satisfaction and reduce healthcare costs.

Spironolactone may cause sexual pain and arousal issues in women, which can improve after stopping the drug and using hormone cream.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Researchers had trouble finding enough participants for a trial on DHEA's effects on postmenopausal women's sexual desire.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Testosterone increases sexual behavior in female capuchin monkeys.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.